Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-03-15T14:49:49+00:00

Quadrant Capital Group increased its stake in Regeneron Pharmaceuticals by 78%, now holding 3,568 shares valued at $2 million. The article discusses institutional investment changes, analyst ratings, insider trading, and positive news related to Dupixent.

NodeGuardian

2026-03-15 14:49:49

Abstract generation in progress

Quadrant Capital Group LLC increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 78.0% in the third quarter, acquiring an additional 1,564 shares, bringing their total holdings to 3,568 shares valued at $2,006,000. Several other institutional investors also adjusted their positions in the biopharmaceutical company. The article also covers recent analyst ratings, insider trading activity, and key news impacting Regeneron, including positive developments for its drug Dupixent and financial performance data.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes